Redmile Biopharma Investments II LP

-

Fund Information and Directors

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Redmile Biopharma Investments II LP
Firm Redmile Group LLC
Fund #805-9153149946
CIK #0001772230
Sale2019-03-22 (675.4 M Offered, 675.4 M Sold)
FundVenture Capital Fund
Phone4154899980
AddressLetterman Digital Arts Center
San Francisco, California 94129
Source [EDGAR] [IAPD]
Fund AUM and Sold ($M)
1400112084056028002010201520212027
Fund Details
DirectorRedmile Biopharma Investments II GP LLC - General Partner
CustodianMorgan Stanley & Co LLC, Silicon Valley Bank NA, First Republic Bank, Carta Securities LLC, JP Morgan Chase Bank NA
AuditorErnst & Young LLP
MarketerHollister Associates LLC, JP Morgan Securities LLC
BrokerMorgan Stanley & Co LLC
Jurisdiction
Form D Offering
Filed2020-03-05 (D/A)
Exemption506(b), 3(c), 3(c)(7)
DurationOne year or less
Commission$7,300,000
RevenueDecline to Disclose
Investors140
DirectorsRole2011 - 2026
Jeremy Green Executive Officer
Redmile Biopharma Investments II GP LLC Promoter
Redmile Group LLC Executive Officer
Amrit Nagpal Executive Officer
Mike Lee Executive Officer
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com